Rheumatology Şule Ketenci Ertaş, MD
✓ Medically verified profileŞule Ketenci Ertaş, MD
Şule Ketenci Ertaş, MD is a Rheumatology specialist at Acibadem in Turkey. Areas of focus include Array. International patients can request a free consultation or a second medical opinion.
Accepting international patientsAbout Şule Ketenci Ertaş, MD
Şule Ketenci Ertaş, MD is a rheumatologist with 7 years of experience. Her listed areas of expertise include IgG4-related disease, Behçet disease, autoimmune rheumatic diseases, musculoskeletal conditions, IgG4-related tubulointerstitial nephritis, and rituximab therapy for IgG4-related disease.
Dr. Ertaş completed specialty training in Rheumatology at Erciyes University Faculty of Medicine in 2019 and Internal Medicine at Erciyes University Faculty of Medicine in 2014. She was a Rheumatology Specialist Dr. at Tokat State Hospital from 2019 to 2020 and at Kayseri City Hospital from 2020 to 2021. She joined Acibadem Health Group in 2021. The profile lists 1 professional body: the Turkish Rheumatology Association.
The profile lists 10 publications dated between 2016 and 2020. Listed subjects include IgG4-related tubulointerstitial nephritis, Behçet disease with vitiligo, and diffuse large B-cell lymphoma. Dr. Ertaş speaks Turkish and English. Online consultation is available, allowing patients abroad to speak with her before travelling.
What Dr. Ertaş treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Conditions treated
- Polymyalgia rheumatica
- Musculoskeletal conditions
- Behçet disease
- Igg4-related disease
- Igg4-related tubulointerstitial nephritis
Procedures performed
- Rituximab therapy for igg4-related disease
- Systemic lupus erythematosus treatment
Education, career and memberships
Education & training
Education
- 2019Erciyes University Faculty of Medicine Rheumatology
- 2014Erciyes University Faculty of Medicine Internal Medicine
- 2007Hacettepe University Faculty of Medicine
Career
Professional Experience
- 2021Acibadem Health Group
- 2020–2021Kayseri City Hospital , Rheumatology Specialist Dr.
- 2019–2020Tokat State Hospital, Rheumatology Specialist Dr.
Memberships
Professional Memberships
- Turkish Rheumatology Association
Selected publications
Selected Publications
- A case of fulminant demyelinating disease associated with golimumab treatment (2020) Yetkin, M. F., Kendirci, M., Ismailogullari, S., Gültekin, M., Baydemir, R., Sarilar, A. Ç., Ertas ŞK,. & Mirza, M.
- Fatigue Is Common and Predicted by Female Gender and Sleep Disturbance in Patients with Chronic Spontaneous Urticaria The Journal of Allergy and Clinical Immunology: In Practice, 2020, 9.1: 469-476. EROL, Kemal; ERTAŞ, Şule Ketenci; ERTAŞ, Ragıp
- Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU Allergy, 75(2), 468-470. (2020) Ertaş, R., Hawro, T., Altrichter, S., Özyurt, K., Erol, K., Ketenci Ertaş, Ş., & Maurer, M.
- Is increased intracranial pressure a reason for headache in COVID-19 patients? Evaluation with optic nerve sheath diameter Zuhal Ozer Simsek, Seda Guzeldag, Sule Ketenci Ertas, Yasemin Dincaslan
- Successful treatment of tubulointerstitial nephritis in immunoglobulin G4-related disease with rituximab: A case report World journal of clinical cases, 7(16), 2309. (2019) Eroglu, E., Sipahioglu, M. H., Senel, S., Ertas, S. K., Savas, S., Ozturk, F., … & Oymak, O.
- Case Report: Behçets disease accompanied with vitiligo F1000Research, 6. (2017) Ertas, R., Ozyurt, K., Avci, A., Ertas, S. K., & Atasoy, M.
- Case Report: Behçets disease accompanied with vitiligo Case Report: Behçet?s disease accompanied with vitiligo (2017) Ragıp, E., Kemal, Ö., Atıl, A., Sule, K. E., & Mustafa, A.
- Immunohistochemical investigation of P16, P53 and Ki-67’s prognostic values in diffuse large B-Cell lymphomas Bratislavske lekarske listy, 118(10), 602-608. (2017) Baran, M., Canoz, O., Altuntas, H., Sivgin, S., Cetin, M.Yay, A., & Ketenci, S.
- Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk Blood pressure, 25(3), 141-148. (2016) Ertas, R., Orscelik, O., Kartal, D., Dogan, A., Ertas, S. K., Aydogdu, E. G., … & Borlu, M
- Mutations in IDH1, IDH2, PON1 genes in patients with diffuse large b-cell lymphoma Current Opinion in Biotechnology, (24), S98. 82013) Akalin, H., Ertas, S. K., Akbarova, Y., Ozkul, Y., & Unal, A.
